Allstate Corporation’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Allstate Corporation's RARE Position: Q3 2026 in Review
Allstate Corporation sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 32,842 shares — an estimated $1.1M sold.
Allstate Corporation first reported a position in RARE in Q1 2026 and held it in 2 quarters. The position peaked at $1.1M in Q2 2026. 263 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Allstate Corporation reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Allstate Corporation sold 32,842 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $1.1M.
- Allstate Corporation first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and held it in 2 quarters.
- Allstate Corporation's Ultragenyx Pharmaceutical position peaked at $1.1M in Q2 2026.
- 263 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.